Literature DB >> 2658787

Interaction of cefpirome and a cephalosporinase from Citrobacter freundii GN7391.

S Satake1, M Hiraoka, S Mitsuhashi.   

Abstract

The interaction of cefpirome and a cephalosporinase from Citrobacter freundii, including hydrolysis and inhibition, was studied in comparison with those of cefotiam, cefotaxime, and ceftazidime. Cefpirome was hydrolyzed by the enzyme more rapidly at Vmax than were cefotaxime and ceftazidime. However, the low affinity of the enzyme for cefpirome caused a reduction in the hydrolytic rate of cefpirome at a low drug concentration (0.1 microM). The high stability of cefpirome at a low concentration explains the high antimicrobial activity of the agent against cephalosporinase-producing bacteria.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2658787      PMCID: PMC171502          DOI: 10.1128/AAC.33.3.398

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  10 in total

1.  Relation between beta-lactamase production and antimicrobial activity: comparison of the new compound HR 810 with cefotaxime.

Authors:  W Cullmann; W Opferkuch; M Stieglitz
Journal:  Eur J Clin Microbiol       Date:  1983-08       Impact factor: 3.267

2.  HR 810, a cephalosporin with low affinity for Enterobacter cloacae beta-lactamase.

Authors:  R M Tolxdorff-Neutzling; B Wiedemann
Journal:  Eur J Clin Microbiol       Date:  1983-08       Impact factor: 3.267

3.  Purification and properties of chromosomally mediated beta-lactamase from Citrobacter freundii GN7391.

Authors:  M Tajima; Y Takenouchi; S Sugawara; M Inoue; S Mitsuhashi
Journal:  J Gen Microbiol       Date:  1980-12

4.  Induction of beta-lactamase by various beta-lactam antibiotics in Enterobacter cloacae.

Authors:  S Minami; A Yotsuji; M Inoue; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1980-09       Impact factor: 5.191

5.  In vitro activity of HR 810, a new cephalosporin.

Authors:  M A Bertram; D A Bruckner; L S Young
Journal:  Antimicrob Agents Chemother       Date:  1984-08       Impact factor: 5.191

6.  Hydrolytic rate at low drug concentration as a limiting factor in resistance to newer cephalosporins.

Authors:  M Hiraoka; M Inoue; S Mitsuhashi
Journal:  Rev Infect Dis       Date:  1988 Jul-Aug

7.  In vitro evaluation of HR810, a new wide-spectrum aminothiazolyl alpha-methoxyimino cephalosporin.

Authors:  R N Jones; C Thornsberry; A L Barry
Journal:  Antimicrob Agents Chemother       Date:  1984-06       Impact factor: 5.191

8.  Cephalosporinase interactions and antimicrobial activity of BMY-28142, ceftazidime and cefotaxime.

Authors:  M Hiraoka; S Masuyoshi; S Mitsuhashi; K Tomatsu; M Inoue
Journal:  J Antibiot (Tokyo)       Date:  1988-01       Impact factor: 2.649

9.  Beta-lactamase stability of cefpirome (HR 810), a new cephalosporin with a broad antimicrobial spectrum.

Authors:  S Kobayashi; S Arai; S Hayashi; K Fujimoto
Journal:  Antimicrob Agents Chemother       Date:  1986-11       Impact factor: 5.191

10.  In vitro activity of HR 810, a new broad-spectrum cephalosporin.

Authors:  K Machka; I Braveny
Journal:  Eur J Clin Microbiol       Date:  1983-08       Impact factor: 3.267

  10 in total
  4 in total

1.  In vitro activity of cefpirome against selected clinical enterobacterial isolates with beta-lactamase-mediated resistance.

Authors:  L S Tzouvelekis; E Tzelepi; A F Mentis; N J Legakis
Journal:  Infection       Date:  1995 Nov-Dec       Impact factor: 3.553

Review 2.  A functional classification scheme for beta-lactamases and its correlation with molecular structure.

Authors:  K Bush; G A Jacoby; A A Medeiros
Journal:  Antimicrob Agents Chemother       Date:  1995-06       Impact factor: 5.191

3.  Interaction of E1040 with cephalosporinase from Citrobacter freundii GN7391.

Authors:  E Inoue; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1989-12       Impact factor: 5.191

4.  Effects of beta-lactamases and omp mutation on susceptibility to beta-lactam antibiotics in Escherichia coli.

Authors:  M Hiraoka; R Okamoto; M Inoue; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1989-03       Impact factor: 5.191

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.